Atrás
También listada como
TLPPF
OTC
Rango del Día
$8.62
$8.89
Rango de 52 Semanas
$6.28
$20.00
Volumen
234,479
Promedio 50D / 200D
$7.42
/
$10.51
Cierre Anterior
$9.13
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -278.1 | 0.3 |
| P/B | 4.8 | 2.9 |
| ROE % | -1.8 | 3.7 |
| Net Margin % | -0.9 | 3.8 |
| Rev Growth 5Y % | 254.9 | 10.0 |
| D/E | 1.3 | 0.2 |
Precio Objetivo de Analistas
Hold
$17.00
+93.8%
P/E Futuro
184.4
EPS Futuro
$0.05
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
1.4 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$1.07
$1.01 – $1.16
|
2.4 B | 3 |
| FY2029 |
$0.79
$0.75 – $0.86
|
2 B | 3 |
| FY2028 |
$0.39
-$0.18 – $0.78
|
1.8 B | 9 |
Puntos Clave
Revenue grew 254.93% annually over 5 years — strong growth
Earnings declined -121.40% over the past year
Negative free cash flow of -82.80M
Revenue growth is decelerating — 1Y growth trails 5Y average by 201.02%
Capital efficient — spends only 4.72% of revenue on capex
ROIC of 1.42% — low return on invested capital
Crecimiento
Revenue Growth (5Y)
254.93%
Revenue (1Y)53.91%
Earnings (1Y)-121.40%
FCF Growth (3Y)N/A
Calidad
Return on Equity
-1.80%
ROIC1.42%
Net Margin-0.89%
Op. Margin2.21%
Seguridad
Debt / Equity
1.26
Current Ratio1.43
Interest Coverage0.48
Valoración
P/E Ratio
-278.06
P/B Ratio4.77
EV/EBITDA132.99
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 53.91% | Revenue Growth (3Y) | 54.88% |
| Earnings Growth (1Y) | -121.40% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 254.93% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.21B | Net Income (TTM) | -10.69M |
| ROE | -1.80% | ROA | -0.60% |
| Gross Margin | 53.11% | Operating Margin | 2.21% |
| Net Margin | -0.89% | Free Cash Flow (TTM) | -82.80M |
| ROIC | 1.42% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.26 | Current Ratio | 1.43 |
| Interest Coverage | 0.48 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -278.06 | P/B Ratio | 4.77 |
| P/S Ratio | 2.46 | PEG Ratio | 2.93 |
| EV/EBITDA | 132.99 | Dividend Yield | 0.00% |
| Market Cap | 2.97B | Enterprise Value | 3.54B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.21B | 783.21M | 502.55M | 160.10M | 7.60M |
| Net Income | -10.69M | 49.92M | 5.21M | -104.08M | -80.51M |
| EPS (Diluted) | -0.03 | 0.14 | 0.02 | -0.34 | -0.29 |
| Gross Profit | 640.23M | 509.68M | 314.39M | 29.34M | -29.77M |
| Operating Income | 26.64M | 82.13M | 51.89M | -91.93M | -81.25M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.77B | 1.52B | 398.30M | 260.59M | 109.81M |
| Total Liabilities | 1.15B | 948.22M | 249.39M | 175.35M | 106.17M |
| Shareholders' Equity | 622.27M | 568.21M | 148.91M | 80.01M | 2.16M |
| Total Debt | 784.47M | 581.45M | 17.45M | 10.45M | 2.54M |
| Cash & Equivalents | 212.53M | 710.35M | 123.24M | 116.33M | 22.04M |
| Current Assets | 494.79M | 918.56M | 224.85M | 173.23M | 47.54M |
| Current Liabilities | 347.00M | 330.91M | 157.41M | 85.56M | 37.98M |